My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Surgery Partners, Inc. - Common Stock (NQ:SGRY)

20.45 +0.06 (+0.29%)
Streaming Delayed Price Updated: 11:04 AM EDT, Oct 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Surgery Partners, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
3 Volatile Stocks That Fall Short
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced... 
Via StockStory
UnitedHealth Group Navigates Turbulent Waters: Q3 2025 EPS Under Significant Pressure Amidst Mounting Headwinds
UnitedHealth Group (NYSE: UNH), a titan in the U.S. healthcare industry, is grappling with a formidable array of financial and operational challenges that are poised to exert immediate and substantial... 
Via MarketMinute
Topics Artificial Intelligence
1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
Earnings Scheduled For August 5, 2025
 
Via Benzinga
Earnings Scheduled For May 12, 2025
 
Via Benzinga
3 Small-Cap Stocks We Think Twice About
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
3 Russell 2000 Stocks We Steer Clear Of
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
1 Healthcare Stock with Solid Fundamentals and 2 We Question
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
Integer Holdings, Astrana Health, Surgery Partners, IQVIA, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
Via StockStory
Topics Economy
Box, Intuitive Surgical, and Surgery Partners Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell. The move came as U.S.... 
Via StockStory
Topics Economy Stocks
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy
SGRY Q2 Deep Dive: Orthopedics and De Novo Expansion Drive Steady Growth
Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.4% year on year to $826.2 million. The company expects the full year’s revenue to... 
Via StockStory
Surgery Partners (SGRY) Q2 Revenue Up 8%
Via The Motley Fool
SURGERY PARTNERS INC (NASDAQ:SGRY) Reports Mixed Q2 2025 Earnings with EPS Beat and Revenue Miss
SURGERY PARTNERS INC (SGRY) reported mixed Q2 2025 results, missing revenue estimates but beating EPS expectations. Shares rose 0.56% pre-market as investors weighed the earnings beat against the... 
Via Chartmill
Topics Earnings
Surgery Partners (NASDAQ:SGRY) Surprises With Q2 Sales
Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.4% year on year to $826.2 million. The company expects the full year’s revenue to... 
Via StockStory
Surgery Partners (SGRY) Reports Earnings Tomorrow: What To Expect
Via StockStory
Topics Artificial Intelligence World Trade
Oscar Health, Surgery Partners, Moderna, Molina Healthcare, and Fortrea Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending... 
Via StockStory
Surgery Partners (SGRY) Stock Trades Up, Here Is Why
Shares of healthcare company Surgery Partners (NASDAQ:SGRY) jumped 4.3% in the morning session after Bank of America Securities resumed coverage on the stock with a 'Buy' rating and a $28 price... 
Via StockStory
Why Surgery Partners (SGRY) Stock Is Trading Up Today
Shares of healthcare company Surgery Partners (NASDAQ:SGRY) jumped 3.3% in the morning session after an analyst at investment firm Benchmark reiterated a "Buy" rating and a $35 price target on the... 
Via StockStory
Topics Economy Government World Trade
1 Healthcare Stock to Keep an Eye On and 2 to Be Wary Of
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
3 Stocks Under $50 in the Doghouse
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
Surgery Partners Stock Slumps 13% After Company Rejects Bain Capital’s Take-Private Proposal
Chairman of the Independent Committee, Brent Turner, said the best path forward for Surgery Partners is to continue operating as an independent publicly traded company. 
Via Stocktwits
Surgery Partners Rejects Bain Capital's Private Buyout Offer, Will Remain Independent
Surgery Partners rejects Bain Capital's acquisition bid, citing greater long-term value as a public company with strong growth potential and strategic plans. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
SGRY Q1 Earnings Call: Volume Growth and Business Mix Shape Outlook Amid Margin Pressures
Healthcare company Surgery Partners (NASDAQ:SGRY) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 8.2% year on year to $776 million. Its non-GAAP profit of $0.04 per share was... 
Via StockStory
Topics Economy World Trade
3 Russell 2000 Stocks with Mounting Challenges
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the... 
Via StockStory
Assessing Surgery Partners: Insights From 4 Financial Analysts
 
Via Benzinga
Q1 Earnings Highlights: Surgery Partners (NASDAQ:SGRY) Vs The Rest Of The Outpatient & Specialty Care Stocks
Let’s dig into the relative performance of Surgery Partners (NASDAQ:SGRY) and its peers as we unravel the now-completed Q1 outpatient & specialty care earnings season. 
Via StockStory
Topics Artificial Intelligence
Surgery Partners Misses Q1 Marks But Sticks To 2025 Outlook
Surgery Partners reported Q1 revenue of $776 million and earnings of 4 cents per share, reaffirming its 2025 guidance despite missing analyst expectations. 
Via Benzinga
Surgery Partners (NASDAQ:SGRY) Posts Q1 Sales In Line With Estimates But Stock Drops
Healthcare company Surgery Partners (NASDAQ:SGRY) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.2% year on year to $776 million. The company’s outlook for the full year was close... 
Via StockStory
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.